Single ‐ and Multiple‐dose Pharmacokinetics and Safety of Pimodivir, a Novel, Non‐Nucleoside Polymerase Basic Protein 2 Subunit Inhibitor of the Influenza A Virus Polymerase Complex, and Interaction With Oseltamivir: A Phase 1 Open‐Label Study in Healthy Volunteers

British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-.

Source: British Journal of Clinical Pharmacology - August 11, 2018 Category: Drugs & Pharmacology Authors: SofieDeleu , Thomas N.Kakuda , KurtSpittaels , Jurgen J.Vercauteren , VeraHillewaert , AmyLwin , LorantLeopold , Richard M.W.Hoetelmans Source Type: research